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Abstract
Rotaviruses are the leading cause of severe dehydrating diarrhea in children worldwide. Rotavirus-induced immune
responses, especially the T and B cell responses, have been extensively characterized; however, little is known about innate
immune mechanisms involved in the control of rotavirus infection. Although increased levels of systemic type I interferon
(IFNa and b) correlate with accelerated resolution of rotavirus disease, multiple rotavirus strains, including rhesus rotavirus
(RRV), have been demonstrated to antagonize type I IFN production in a variety of epithelial and fibroblast cell types
through several mechanisms, including degradation of multiple interferon regulatory factors by a viral nonstructural
protein. This report demonstrates that stimulation of highly purified primary human peripheral plasmacytoid dendritic cells
(pDCs) with either live or inactivated RRV induces substantial IFNa production by a subset of pDCs in which RRV does not
replicate. Characterization of pDC responses to viral stimulus by flow cytometry and Luminex revealed that RRV replicates in
a small subset of human primary pDCs and, in this RRV-permissive small subset, IFNa production is diminished. pDC
activation and maturation were observed independently of viral replication and were enhanced in cells in which virus
replicates. Production of IFNa by pDCs following RRV exposure required viral dsRNA and surface proteins, but neither viral
replication nor activation by trypsin cleavage of VP4. These results demonstrate that a minor subset of purified primary
human peripheral pDCs are permissive to RRV infection, and that pDCs retain functionality following RRV stimulus.
Additionally, this study demonstrates trypsin-independent infection of primary peripheral cells by rotavirus, which may
allow for the establishment of extraintestinal viremia and antigenemia. Importantly, these data provide the first evidence of
IFNa induction in primary human pDCs by a dsRNA virus, while simultaneously demonstrating impaired IFNa production in
primary human cells in which RRV replicates. Rotavirus infection of primary human pDCs provides a powerful experimental
system for the study of mechanisms underlying pDC-mediated innate immunity to viral infection and reveals a potentially
novel dsRNA-dependent pathway of IFNa induction.
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Introduction
Dendritic cells (DCs), a highly specialized subset of professional
antigen-presenting cells, play a central role in the initiation of
innate and adaptive immunity. There are two known major
subsets of primary human and murine circulating DCs: myeloid
DCs, which function principally in antigen presentation, and
plasmacytoid DCs (pDCs), which secrete the type I interferons
(IFN), IFNa and IFNb [1], as well as a variety of other cytokines
and chemokines. Viral induction of type I IFN expression has been
well studied in recent years and has been shown to be mediated by
multiple pattern recognition receptors (PRRs), including retinoic
acid-inducible gene (RIG)-I, melanoma differentiation-associated
gene (MDA)5, toll-like receptor (TLR)3, TLR7 and TLR9. PRR
expression is restricted in pDCs, with only TLR7 and TLR9
implicated in viral-induced IFNa production through the
recognition of single-stranded (ss)RNA or DNA, respectively
[2,3,4,5,6,7,8,9]. IFNa production by pDCs is also observed
following TLR7/8 stimulus with synthetic resiquimods and
imiquimods, or TLR9 antagonism by CpG oligodeoxynucleotides
(ODN). pDCs are not generally thought to be able to respond to
double-stranded (ds)RNA, as stimulation with poly I:C or long
(500 base pairs) dsRNA molecules fail to elicit IFNa or upregulate
activation or maturation markers, such as CD86 and CD83
[10,11,12]. However, low levels of IFNa production have been
reported following pDC stimulation with poly A:U [13] or in vitro
transcribed viral dsRNA [11], and a recent report indicates a role
for RIG-I-like helicases in recognizing replicating virus in murine
pDCs lacking the IFN receptor [14]. Short interfering dsRNAs
have also been demonstrated to elicit an IFNa response through
PLoS Pathogens | www.plospathogens.org 1 June 2010 | Volume 6 | Issue 6 | e1000931TLR7, although this appears dependent on a specific sequence,
and not on the dsRNA structure [12].
It is well understood that pDCs activate natural killer cells [15],
macrophages [15,16] and T and B cells [17,18], presumably, in
part, through IFNa stimulus. Recent evidence suggests that pDCs
may have additional antiviral effects, including the direct
inhibition of viral replication in target cells secondary to the
secretion of type I IFN [19,20,21]. pDCs are also implicated in
restricting viral replication in vivo, as there is an inverse correlation
between circulating pDC numbers and human immunodeficiency
virus (HIV) or hepatitis C virus (HCV) viral load [22,23,24,25].
Rotavirus, a dsRNA icosahedral virus in the Reoviridae family, is
the leading cause of severe dehydrating diarrhea in young children
worldwide, with 500,000 to 600,000 annual deaths attributed to
rotavirus infections [26,27,28,29]. Significant morbidity and
economic impact are the main effects in the United States,
accounting for approximately 50,000 to 60,000 hospitalizations a
year and loss of time from work for caregivers [30].
Rotaviruses are characterized by a triple-layered protein capsid
composed of four major structural proteins. Viral protein (VP)2
comprises the innermost layer, in which the dsRNA genome is
contained, while the middle layer consists of VP6. The outer layer
of the virion is composed of the VP7 glycoprotein and protease-
sensitive VP4 spikes [31]. Although both triple- and double-
layered particles (TLPs and DLPs, respectively) are generated
during rotavirus replication, only TLPs are infectious, due to the
requirements of VP4 and VP7 for cell binding, and trypsin
cleavage of VP4 for viral entry and infectivity [32,33,34,35,36].
Formation of noninfectious empty TLPs and DLPs, which lack the
viral genome, is also observed during infection. The nonstructural
proteins (NSP1 through 5) are involved in viral replication,
morphogenesis and assembly, but they are not expressed by
nonreplicating virus and are not part of the infectious virion [31].
Rotavirus-induced immune responses, especially the T and B
cell responses, have been extensively characterized; however, little
is known about innate immune mechanisms required to control
rotavirus infection. Rotavirus structural and nonstructural proteins
have been detected in primary DCs from murine mesenteric
lymph nodes and spleens [37,38], and murine bone marrow-
derived DCs have been shown to secrete type I IFN and tumor
necrosis factor (TNF)a following rhesus (RRV) or bovine rotavirus
(RF-81) challenge, respectively [39,40]. Mature human monocyte-
derived myeloid DCs (moDCs) have been demonstrated to be
more susceptible to rotavirus infection than immature moDCs,
although infection did not result in substantial cell death [41].
Additionally, infection did not induce moDC maturation, but
instead promoted priming of Th1 cells [41]. A recent study of total
human peripheral blood mononuclear cells (PBMCs) exposed to
RRV or human rotavirus indicated that both myeloid DCs and
pDCs are susceptible to infection, and that infection results in the
secretion of IFNa, presumably from pDCs [42]. While increased
levels of IFNa have also been correlated with a positive clinical
outcome in infected children [43,44], several rotaviruses, including
RRV, have recently been demonstrated to antagonize the
production of type I IFN through the degradation of interferon
regulatory factors (IRF)3, IRF5, and IRF7, and the inhibition of
NFkB activation, by a viral nonstructural protein, NSP1
[45,46,47,48].
Here we report the effects of rotavirus infection on highly
purified primary human pDCs. We demonstrate that although
rotavirus initiates detectable transcription and translation in only a
small percentage of pDCs, a significant percentage of pDCs
activate and mature following exposure to virus. Importantly, we
demonstrate that stimulation of pDCs with live or inactivated
RRV effects secretion of IFNa and multiple proinflammatory
cytokines and chemokines. This response is dependent on the
presence of the viral dsRNA genome. As IFNa production by
pDCs is classically triggered in response to ssRNA or DNA, the
induction of this response by a replication-incompetent dsRNA
virus indicates a potentially novel mechanism of viral sensing by
pDCs.
Results
A subpopulation of human primary peripheral pDCs is
permissive to RRV replication
To characterize the interaction between pDCs (phenotypically





S1) and rotavirus, pDCs were purified from human blood by
negative selection (mean purity 6 standard error mean [SEM]:
86.48%60.92) and exposed to RRV at a multiplicity of infection
(moi) of 5 or 10, or to equivalent quantities of inactivated RRV
(iRRV). Expression of NSP2, a viral nonstructural protein
expressed only in cells in which rotavirus replicates, was detected
by intracellular flow cytometry at 6 and 12 hours post infection
(hpi). As illustrated in Figure 1, NSP2 was not detected in pDCs
receiving MA104 supernatant (mock-treated; Figure 1A) or iRRV
(data not shown), but was expressed in a small but significant
percentage (mean 6 SEM, moi 5: 1.18%60.23 6hpi,
1.43%60.28 12hpi; moi 10: 1.45%60.25 6hpi, 3.02%60.99
12hpi) of pDCs inoculated with live RRV (Figure 1B and 1D).
Additionally, NSP2 was detected only after pDCs were permea-




bright, were frequently apparent in pDCs
exposed to live RRV (Figure 1B and 1C); approximately 20% of
donors had only a single NSP2
dim population. While the total
percent of pDCs expressing NSP2 following RRV challenge
increased from 6 to 12hpi, this increase was not significant (moi 5:
p=0.77; moi 10: p=0.30; Mann-Whitney) (Figure 1D). The
percent of NSP2
+ pDCs also increased with moi (6hpi: p=0.26;
12hpi: p=0.063; Mann-Whitney), but remained a minor
proportion of the total pDC population (median: 2.01%, moi
Author Summary
Rotaviruses cause severe dehydrating diarrhea and are a
leading cause of death in children worldwide. A potent
antiviral, interferon-a (IFNa), is rapidly secreted by
plasmacytoid dendritic cells (pDCs) in response to viral
single-stranded RNA or DNA genomes. Here, we examined
the effects of rotavirus on pDCs purified from human
blood. We found that very few pDCs supported rotavirus
replication, and that pDCs retained similar functionality in
response to live or inactivated rotaviruses. While pDCs
produced large quantities of IFNa shortly after rotavirus
exposure, this was impaired in cells supporting viral
replication. We also found that two viral proteins and the
rotavirus double-stranded RNA genome were required for
the initiation of the pDC IFNa response to rotavirus.
Additionally, we found that cleavage of one of these viral
proteins, a traditional prerequisite for rotavirus infection in
other cell types, was not required for the infection of pDCs
or production of IFNa. This may enable the host to rapidly
initiate an immune response to rotavirus that subsequent-
ly restricts infection to the intestine and contributes to the
resolution of disease. Our study provides novel insight into
the interaction between rotavirus and the host innate
immune response, and also identifies a unique mechanism
for the production of IFNa by pDCs.
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modestly increased the NSP2
+ population, but it remained
relatively small (mean: 4.99%, median: 2.07%, moi 100, n=4,
data not shown). pDCs from multiple donors (n=5, mean purity:
91.51%) were titered after overnight culture to determine whether
rotavirus infection was productive. A significant increase in viral
titer (approximately 20-fold, p#0.03; Wilcoxon signed rank test)
(data not shown) was observed in two of these donors, while the
other three showed no significant change over time (p$0.17;
Wilcoxon signed rank test) (data not shown). While pDC viability
was significantly decreased from 6 to 12hpi in cultures receiving
mock, RRV (moi 5) or iRRV stimulus (p#0.004; Mann-Whitney),
viral exposure did not result in significant cell death compared to
mock stimulus at a given time point (p.0.063; Wilcoxon signed
rank test) (Figure 1E). The low frequency of NSP2
+ pDCs shows
that the majority of human pDCs are resistant to RRV replication,
as defined by evidence of expression of a non-structural rotavirus
protein.
pDCs activate and mature following RRV stimulation
To establish whether pDCs activate or mature following
inoculation with RRV, the frequency of pDCs expressing markers
Figure 1. Infection of human peripheral pDCs with rhesus rotavirus. Replication of rhesus rotavirus (RRV) in pDCs was assessed by
intracellular staining for NSP2. (A, B) Representative FACS plots of purified pDCs exposed to MA104 supernatant alone (A) or live RRV (moi 10, B) 6 hpi.
(C) Representative histogram demonstrating NSP2
dim and NSP2
bright populations. (D) Percent NSP2
+ pDCs from multiple healthy donors (n=9–37)
exposed to mock or RRV (moi 5 or 10) stimulus at 6 or 12 hpi. **: p=0.0039; ***: p#0.0002 by Wilcoxon signed rank test. (E) Percent viable pDCs 6 or
12 h following mock or rotavirus stimulus. p$0.125 vs. mock; Wilcoxon signed rank test.
doi:10.1371/journal.ppat.1000931.g001
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flow cytometry. pDC activation (Figure 2A and 2C) and
maturation (Figure 2B and 2D) occurred at similar levels 12h
after stimulation with either live or inactivated rotavirus (p$0.125;
Wilcoxon signed rank test), and were significantly increased
compared to mock-stimulated cells (p#0.03; Wilcoxon signed rank
test). Stimulation with CpG ODN 2395 resulted in activation of a
significantly greater percentage of the pDC population than that
observed in pDCs exposed to RRV (p=0.03; Wilcoxon signed
rank test). The percent of pDCs matured by CpG ODN 2395
stimulus was also increased, but not significantly compared to
those exposed to RRV (p=0.094; Wilcoxon signed rank test).
Viral replication did not inhibit maturation or activation, as pDCs
positive for NSP2 expressed CD86 and CD83 at a significantly
higher frequency (p#0.008; Wilcoxon signed rank test) than
bystander pDCs (Figure 2E-H). Expression of both molecules was
significantly increased in both populations compared to pDCs
receiving mock stimulus. Together, these data demonstrate that
pDCs retain the ability to activate and mature after viral exposure,
likely due to secondary effects, as the presence of replicative
rotavirus is dispensable for induction of these phenotypes.
Cytokine production by human primary pDCs in
response to rotavirus is independent of viral replication
Production of IFNa is an important component of the pDC-
derived antiviral response. To assess this component of the pDC
anti-rotaviral response, the frequency of cells expressing IFNa was
determined by flow cytometry. Intracellular IFNa was detected
within 4hpi of RRV stimulus, peaked at 6hpi and was sustained
until at least 12hpi (Figure 3A and 3B). IFNa was detected
intracellularly at similar frequencies in pDCs exposed to iRRV
(which was both infectivity and transcriptionally negative)
(p=0.815; Mann-Whitney) (Figure 3A and data not shown),
suggesting that replication or transcription of rotavirus is largely
dispensable for IFNa induction in human pDCs. Intracellular
IFNa was abrogated by the addition of RRV neutralizing VP7 or
VP4 monoclonal antibodies (either mAb 159 or 2G4), indicating
that the observed induction was virus-specific and likely dependent
on an event occurring after virus binding and entry (Figure 3C)
[49]. To identify and quantify IFNa secretion, and to detect other
cytokines and chemokines secreted in response to RRV exposure,
Luminex assays or ELISAs were performed on supernatants
collected from inoculated pDCs at various times post infection.
Only supernatants from pDC cultures $85% pure (mean:
90.84%60.75; n=3–18) were analyzed to minimize the contri-
bution of contaminating cells to the cytokine milieu. A significant
IFNa response, approaching 10,000 pg IFNa/ml, was detectable
6h following exposure to live or inactivated RRV (Figure 4A). In
addition, significant quantities of IFNb, TNFa, interleukin (IL)6,
IL8, CXCL10 (IP10), CCL3 (MIP1a), CCL4 (MIP1b), CCL5
(RANTES) and TNFb were detected at various times post
infection (Figure 4B-I and data not shown). Together, these data
suggest that live or inactivated RRV rapidly induce production of
significant levels of IFNa and other proinflammatory cytokines
and chemokines by pDCs.
IFNa production is impaired in pDCs undergoing RRV
replication
In contrast to what was observed with pDC activation and
maturation, IFNa production was significantly reduced in NSP2
+
pDCs (Figure 5). NSP2
- bystander pDCs produced IFNa at a
significantly increased frequency (p,0.0001; Wilcoxon signed
rank test) compared to pDCs dim or bright for NSP2 (Figure 5A
and 5B). The percent of IFNa
+ pDCs was significantly increased in
the NSP2
dim population compared to that in the NSP2
bright
(p=0.0006; Wilcoxon signed rank test), supporting the hypothesis
that increased levels of RRV infection are inversely correlated with
IFNa production. More significant was the sustained production
of IFNa in uninfected (NSP2
-) pDCs following RRV stimulus. A
similar correlation between NSP2 expression and IFNb produc-
tion was also observed (Figure 5C). These data indicate that
infection in a minor subset of pDCs results in the local suppression
of the IFNa response in these specific cells.
IRF7 is phosphorylated in pDCs supporting low levels of
viral replication
To further investigate the impairment of the IFNa response in
pDCs undergoing rotavirus replication, phosphorylation of IRF7,
the key transcription factor for the IFNa response in pDCs [50],
was assessed by phosflow (Figure 5D and 5E). In accordance with
the decreased production of IFNa by NSP2
bright cells compared to
that of NSP2
dim pDCs, as well as previous findings of IRF7
degradation in rotavirus-infected cells [45,46], phosphorylated
IRF7 (pIRF7) was substantially decreased in pDCs bright for
NSP2 (p=0.03 versus NSP2
dim pDCs; Wilcoxon signed rank test)
(Figure 5D and 5E), and is similar to that of IFNa
-NSP2
- pDCs
(p=0.56; Wilcoxon signed rank test) (Figure 5E). To determine
whether this decrease in pIRF7 was due to decreased levels of total
IRF7 in pDCs, the MFI of total IRF7 was assessed (Figure 5F).
While the total IRF7 MFI was slightly depressed in NSP2
bright
compared to NSP2
dim pDCs, this decrease was not significant
(p=0.44; Wilcoxon signed rank test) and thus does not account for
the observed differences in IRF7 phosphorylation. The increased
levels of pIRF7 in NSP2
dim pDCs may represent continual, direct
stimulus of the IRF7 pathway in virus-positive pDCs, as well as a
mechanism by which the IFNa response is directly initiated.
Alternately, pIRF7 may be sequestered in a nontraditional cellular
compartment prior to degradation, leading to increased protein
accumulation. Interestingly, levels of IRF7 phosphorylation in
IFNa
+NSP2
- pDCs were intermediate to that of NSP2
dim




- pDCs (p=0.0313; Wilcoxon signed rank test)
(Figure 5E). The slight depression of pIRF7 in the IFNa
+
population compared to that observed in NSP2
dim pDCs may be
attributable to the enhanced IFNa production in this subpopula-
tion. As pIRF7 is degraded following the initiation of IFNa
transcription, cells in which IFNa has been transcribed would be
expected to have lower levels of pIRF7 than those negative for
IFNa. Notably, inhibition of IFNa secretion, achieved by
simultaneous addition of brefeldin A with viral inoculation,
decreased the percent of IFNa
+ pDCs by an average of 63.5%
(n=6, data not shown). This supports the notion that recognition
of secreted IFNa is an essential component of the IFNa response
following rotavirus exposure, as has been reported with Newcastle
disease virus [14]. Importantly, this is the first demonstration of
impaired IRF phosphorylation in primary human cells infected
with rotavirus.
Trypsin cleavage of VP4 is dispensable for pDC infection
and IFNa induction
Trypsin-mediated cleavage of VP4 is canonically required for
productive entry of rotavirus into permissive cells [33,34,35,36].
However, it has previously been reported that murine bone
marrow-derived DCs activate following exposure to uncleaved
bovine rotavirus [40], indicating that VP4 cleavage may be
dispensable for the induction of the DC response. To investigate
Rotavirus dsRNA Induces IFNa in Human pDCs
PLoS Pathogens | www.plospathogens.org 4 June 2010 | Volume 6 | Issue 6 | e1000931Figure 2. Peripheral pDC activation and maturation following exposure to live or inactivated RRV. The ability of live or inactivated RRV
(moi 5), or CpG 2395 (4 mg/ml), to stimulate pDCs was assessed by flow cytometry for expression of activation (A, C, CD86) or maturation (B, D, CD83)
markers 12h following stimulus. (A, B) Summary of multiple donors (n=5–13). *: p=0.0313; ***: p#0.0005; Wilcoxon signed rank test. (C, D)
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infection of, and IFNa production by, human pDCs, we exposed
pDCs to RRV grown in the absence of trypsin (non-trypsinized;
NT-RRV). Although subsequent exposure to trypsin (thus cleaving
VP4) increased infectivity of the uncleaved NT-RRV preparation
63-fold by plaque titration and intracellular NSP2 staining by 20-
fold in MA104s (data not shown), examination of NSP2 staining
showed that similar proportions of pDCs were infected with either
the cleaved or uncleaved NT-RRV preparations (p=0.625;
Wilcoxon signed rank test) (Figure 6A-C). Likewise, uncleaved
NT-RRV induced IFNa production by a similar (p=0.375;
Wilcoxon signed rank test) percentage of pDCs, compared to
cleaved NT-RRV (Figure 6A, 6B and 6D). Thus, cleavage of VP4
by trypsin is dispensable for both pDC infection and IFNa
induction by RRV.
IFNa induction requires VP4 and/or VP7, and dsRNA
Although the ability of pDCs to mount an IFNa response to
viral infection is well described, the only documented viral TLR
ligands for pDCs are ssRNA and DNA [2,3,7,8,9]. As rotavirus is
a dsRNA virus and since psoralen-treated, transcriptionally-
inactive rotavirus efficiently induced IFNa (Figures 3 and 4A),
we investigated the viral requirements for IFNa induction. pDCs
stimulated with equal quantities (see Methods describing particle
quantification) of purified TLPs, DLPs, empty particles, or
genome-free recombinant virus-like particles (VLPs) were stained
for intracellular IFNa. As expected, density gradient purified RRV
TLPs stimulated similar levels (p=0.695; Wilcoxon signed rank
test; n=10) of IFNa production compared to pDCs treated with
unpurified live or inactivated RRV expressing equivalent amounts
of VP4, as measured by hemagglutination titer (Figure 7). pDCs
exposed to 2/6 genome-containing RRV DLPs expressed neither
IFNa nor NSP2, indicating a likely dependence on VP4 or VP7
for viral entry, as previously reported [32]. Alternately, one or
both of these viral proteins could be serving as the pathogen-
associated molecular pattern (PAMP) responsible for inducing the
pDC IFNa response. To address this, pDCs were stimulated with
2/4/6/7 VLPs or 2/6/7 green fluorescent protein (GFP)-VLPs.
Both 2/6/7 GFP-VLPs and 2/4/6/7 VLPs were capable of
entering pDCs, but failed to induce IFNa (Figure 7 and data not
shown). 2/6 VLPs were comparatively defective in the ability to
enter pDCs (data not shown), thus supporting the hypothesis that
DLPs fail to induce IFNa due to inefficient viral entry. The ability
of infectious SA11, the parental virus from which the 2/4/6/7
VLPs were derived, to induce IFNa production (Figure 7) suggests
that the lack of IFNa following inoculation with 2/4/6/7 VLPs
was due to the absence of a viral genome, and not to strain
variation in surface proteins. Consistent with this hypothesis, IFNa
was detected in very few pDCs exposed to empty TLPs, as
compared to pDCs exposed to equal quantities of genome-
containing TLPs. Instead, IFNa production by pDCs exposed to
empty particles was consistent with that observed in pDCs
inoculated with an equal infectious dose of TLPs, suggesting that
residual contaminating viral genome was responsible for IFNa
production by the empty TLPs. Together, these data indicate that
viral entry, mediated by VP4 and/or VP7, and the viral dsRNA
genome are likely required for rotavirus-induced IFNa production
by pDCs.
Endosomal acidification is required for initiation of the
pDC IFNa response to rotavirus
To begin to characterize the mechanism by which pDC
recognition and subsequent induction of the IFNa response occurs
following rotavirus exposure, pDCs were treated with concana-
mycin A, a potent inhibitor of endosomal acidification, and thus
TLR7/9 function [9,51,52], prior to inoculation with either live or
inactivated RRV at an moi of 10 (Figure 8A–8C). Subsequent
examination of intracellular IFNa production revealed significant
inhibition in concanamycin-treated pDCs compared to untreated
cells (mean 6 SEM, RRV: 83.3%64.6; iRRV: 83.2%64.5;
p=0.01; Mann-Whitney). To determine whether the observed
lack of IFNa production was due to a defect in viral entry,
concanamycin-treated pDCs were examined for NSP2 expression.
Interestingly, NSP2 expression was significantly increased in
concanamycin-treated pDCs compared to untreated cells
(Figure 8D and 8E) (mean fold increase: 5.9; p=0.03; Wilcoxon
signed rank test; n=6). These data indicate that concanamycin-
induced inhibition of endosomal acidification does not inhibit viral
infection of pDCs and hence, presumably, does not restrict viral
entry. These data support the conclusion that concanamycin A
treatment prevents the pDC IFNa response at the level of ligand
recognition, implicating TLR7 or TLR9. Additionally, the data
suggest that the observed low levels of viral replication in pDCs
(Figure 1D) are due, at least in part, to suppression by the pDC
IFN response, as NSP2 expression significantly increases following
IFNa inhibition (Figure 8C and 8D). Notably, these experiments
demonstrate that endosomal acidification is required for the pDC
IFNa response to rotavirus, and provide indirect evidence for the
involvement of an endosomal receptor, such as TLR7 or TLR9, in
the induction of this response.
Discussion
pDCs play a vital role in the generation of innate and adaptive
immunity following viral infection, primarily through the produc-
tion of large quantities of IFNa in response to stimulus of TLR7 or
TLR9 PRRs by ssRNA or DNA PAMPs, respectively. Traditional
receptors for dsRNA, such as RIG-I, MDA5 and TLR3, are
largely thought to not play a role in the initiation of the IFN
response in human pDCs [2,3,4,5,6,7,8,9]. Although Newcastle
disease virus normally elicits an IFNa response in murine pDCs
through triggering TLR7, RIG-I-like helicases have been recently
implicated in IFNa induction by replicating virus in murine pDCs
lacking the IFN receptor [14]. Hence, the mechanisms governing
efficient IFNa induction in these cells by transcriptionally
inactivated, replication-incompetent dsRNA rotavirus are not yet
understood. As rotaviruses represent a large burden of human
disease, it will be important to better understand the immune
mechanisms underlying their recognition and subsequent gener-
ation of antiviral immunity.
In the present study, we demonstrate that primary human pDCs
are largely resistant to rotavirus replication, as intracellular
Representative histograms showing pDC activation (C) or maturation (D) following exposure to MA104 supernatant alone (dotted line), CpG 2395
(4 mg/ml; shaded) or RRV (moi 5; bold line). (E-H) To determine whether viral replication affected the pDC response, cells exposed to live RRV were
gated based on NSP2 expression. The expression of CD86 (E, G) and CD83 (F, H) by NSP2
+ and bystander (NSP2
-) pDCs was subsequently assessed. (E,
F) Summary of percent CD86
+ (E) or CD83
+ (F) pDCs in NSP2
+ or bystander pDC populations from multiple donors 12hpi (n=8–9); p#0.0078;
Wilcoxon signed rank test. (G, H) Representative histograms showing pDC activation (G) or maturation (H) of NSP2
+ (bold) or NSP2
- bystander (thin
line) pDCs in cultures exposed to RRV (moi 5) or mock stimulus (dotted line).
doi:10.1371/journal.ppat.1000931.g002
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PLoS Pathogens | www.plospathogens.org 6 June 2010 | Volume 6 | Issue 6 | e1000931Figure 3. Intracellular production of IFNa by pDCs after exposure to live or inactivated RRV. (A) Representative FACS plots of IFNa vs.
CD123 expression by pDCs exposed to mock, iRRV or RRV stimulus 2-6hpi (moi 5). (B) Time course of IFNa induction in pDCs after mock or RRV (moi
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of cells following RRV exposure, even at a non-physiologically
relevant moi of 100. While productive infection was observed in a
subset of donors, this was significantly less than that observed in
cells highly permissive for rotavirus infection [53]. As rotavirus is
generally a lytic virus [31,54,55], the observed lack of significant
death in pDC preparations exposed to live RRV, compared to
those receiving mock stimulus or inactivated virus, further
indicates that few pDCs are permissive to viral replication. These
findings are in agreement with previous reports of low frequencies
of pDC infection in virus models such as herpes simplex virus 2
[56], Dengue [57], human cytomegalovirus [17], influenza [58],
HCV [24] and HIV [59]. The inability of the primary human
peripheral pDC population to be uniformly infected by rotaviruses
may be attributable to multiple factors, including age of the
individual pDC, stage of the cell cycle, or cell-surface marker
expression. Additionally, functionally-distinct pDC subsets have
been recently identified on the basis of CD2 expression [60];
studies are currently underway to elucidate the role of these subsets
in the pDC response to rotavirus.
Consistent with the general resistance to rotavirus infection,
pDCs retained several important functional abilities following
RRV exposure, as evidenced by their activation, maturation and
cytokine production. Evidence of this functionality was observed
primarily in the major NSP2
- bystander population, although
activation and maturation were significantly enhanced in the few
NSP2
+ pDCs, as well. The induction of this phenotype by
inactivated RRV further indicates that the pDCs are responding
to the presence of input virus or to secreted factors, and not to viral
replication. The upregulation of DC costimulatory and maturation
markers suggests antigen presentation to T cells is preserved, in
line with previous reports that pDCs are necessary for stimulation
of IFNc-secreting memory T cells [42]. The antigen presentation
hypothesis is supported by increased expression of CD86 and
CD83 on NSP2
+ pDCs compared to bystander pDCs, indicating
that the presence of virus enhances this phenotype. Conversely,
IFNa/b production is impaired in NSP2
+ pDCs. Combined with
decreased IRF7 phosphorylation in NSP2
bright pDCs, this suggests
the direct inhibition of the type I IFN response by rotavirus
replication, as has been previously observed in fibroblasts and
epithelial cells [45,46,47,48].
This study is the first to demonstrate that rotavirus, a segmented
dsRNA virus, directly induces IFNa and IFNb production by
primary human pDCs. While it has previously been reported that
exposure to rotavirus induces IFNa secretion by murine FLT3
ligand-driven pDCs [39] and total human PBMCs [42], and that
this response required pDCs [42], it was unclear until now
whether pDCs produced IFNa directly in response to virus, or if
pDCs amplified IFNa production in response to type I IFN or
some other signal from a non-pDC. In a limited number of
experiments, Mesa et al [42] observed not only pDCs singly
positive for IFNa or rotavirus, but also cells double-positive for
rotavirus and IFNa at a greater frequency than that reported here.
It is important to note that Mesa et al used NSP4 as a marker for
rotavirus infection. Extracellular NSP4 has been identified on
uninfected cells [61]. Conversely, NSP2, employed in this report,
to date has only been detected intracellularly. As such, the
percentage of cells identified as positive for rotavirus on the basis of
NSP4 staining could be inflated versus those expressing NSP2, as
NSP4 staining may include pDCs not truly supporting viral
replication; in turn, the percent of NSP4
+IFNa
+ pDCs would be
artificially increased. This, combined with differences in sample
size, may explain the discrepancies in the incidence of
NSP4
+IFNa
+ pDCs (n=3) observed by Mesa et al and the
frequency of NSP2
+IFNa
+ pDCs (n=27) reported here.
pDCs possess a seemingly unique phenotype in the context of
rotavirus infection, as the ability of NSP1 to degrade multiple IRFs
appears to subvert the type I IFN response in many other cells,
including epithelial and fibroblastic cells [45,46,62]. Presumably,
the constitutive expression of IRF7 in pDCs [63] allows for rapid
induction of IFNa following rotavirus exposure, thus effectively
suppressing viral replication—and the production of NSPs—in the
majority of pDCs through the establishment of a largely paracrine-
induced antiviral state. This conclusion is supported by the
observed lack of significant increase in the NSP2
+ or IFNa
+ pDC
populations when the moi is increased to 25 or 100 (data not
shown). Importantly, the decrease in IFNa and pIRF7 in pDCs
expressing high levels of NSP2 illustrates that the local suppression
of the interferon response by actively replicating virus
[45,46,47,48] is conserved in human pDCs at an individual cell
level. However, inhibition in this minor population is unlikely to
substantially modulate the amount of cytokine produced by the
total pDC population. The present study provides the first formal
demonstration of type I IFN inhibition in primary human cells in
which rotavirus replicates.
The uniqueness of pDCs in the context of rotavirus infection is
further demonstrated by the ability of trypsinized and non-
trypsinized rotavirus to induce IFNa and NSP2 expression at
similar frequencies. The long-standing understanding of the
requirement for VP4 proteolytic cleavage by luminal trypsin to
activate viral entry and infection in the gut led to the assumption
that efficient rotavirus infection could not occur systemically due
to absence of appropriate extracellular proteases. Rotavirus
infection was thought to be largely constrained to the intestine
because this was the only anatomical location with substantial
amounts of active extracellular trypsin available. The apparent
dispensability of this proteolytic requirement for pDC infection
may represent an alternate mechanism of rotavirus entry. This
‘‘non-trypsin dependent’’ mechanism of infectious entry might also
account for the low levels of systemic organ infection and spread
that normally occurs during rotavirus infection, and the elevated
levels seen during rotavirus infection of highly immunocompro-
mised people or animals, where the systemic availability of trypsin
to proteolytically activate rotavirus is unlikely. Additionally, this
provides a mechanism for the establishment of an antiviral state
systemically, where circulating virus would not be expected to be
able to infect cells in the traditional, trypsin cleavage-dependent,
manner.
We have demonstrated that both live and inactivated rhesus
rotavirus efficiently stimulate secretion of type I IFN, in addition
to many other cytokines, suggesting that transcription of viral
nucleic acid is not required for either viral recognition or
subsequent cytokine production by primary human pDCs.
Conversely, viral replication is required for activation of the
IFN response in fibroblasts [62]. Indeed, further analysis of the
viral requirements for IFNa induction suggests that pDCs
recognize and respond to input rotavirus dsRNA or some
degradation product of the rotavirus genome. This is supported
by the inability of genome-free TLPs to effect IFNa secretion,
indicating that the lack of IFNa induction following VLP-
5) stimulus (n=3–30). *: p=0.0313; ***: p#0.0002; Wilcoxon signed rank test. (C) IFNa induction and NSP2 production in pDCs exposed to RRV in the
presence or absence of neutralizing VP4 (2G4) or VP7 (159) mAb.
doi:10.1371/journal.ppat.1000931.g003
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the lack of a minor structural protein, such as VP1 or VP3. To
our knowledge, this is the first direct demonstration of the
requirement for native viral dsRNA in the initiation of an IFNa
response from primary human pDCs.
Importantly, this finding may represent an alternative mecha-
nism of IFNa induction in primary human pDCs. The ability of a
pDC that takes up rotavirus to mount a vigorous type I IFN
response independently of rotavirus mRNA or protein expression
provides a potential mechanism by which the host could effectively
Figure 4. Cytokine secretion by pDCs following exposure to live or inactivated RRV. Detection of secreted IFNa (A), IFNb (B), TNFa (C), IL6
(D), IL8 (E), CXCL10 (IP10) (F), CCL3 (MIP1a) (G), CCL4 (MIP1b) (H), and CCL5 (RANTES) (I) in culture supernatants (n=3–18) from pDCs (1 million per
mL) exposed to mock, live or inactivated RRV (moi 5) stimulus at various times post infection by Luminex or ELISA. TNFb (LTA): #100 pg/mL detected
post viral stimulus. sCD40L: no observed increase versus mock stimulus. Not detected: IFNc, IL10, IL12p40, IL12p70, IL1b, IL1RA, IL2 and IL4.
*: p#0.0265; **: p#0.0091; ***: p#0.0008; Mann-Whitney.
doi:10.1371/journal.ppat.1000931.g004
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[62]. At least three possible mechanisms exist for this phenotype:
first, input or self nucleic acid released from necrotic or apoptotic
cells may serve as PAMPs in neighboring cells, as has been
previously described [64]. As RRV exposure, either to replication-
competent or inactivated virus, does not induce substantial pDC
death (Figure 1), and as the cytokine response occurs rapidly
following infection, this scenario seems unlikely. Secondly, input
viral dsRNA may be exposed in the cytosol, the traditional cellular
location for rotavirus replication, through the process of viral
replication and interact with a cytosolic receptor such as RIG-I or
protein kinase R (PKR). Rotavirus and reovirus, both members of
the Reoviridae family, have been demonstrated to induce IFNb
production in epithelial and human embryonic kidney 293T cells,
respectively, via RIG-I, but not PKR or TLR3 [65,66]. The
mechanism by which input viral genomic RNA recognition might
occur is unclear, however, as viral dsRNA is thought to remain
encapsidated in the DLP and not be free in the cytoplasm during
viral replication. Finally, rotavirus particles may be taken up by and
degraded within the endosome, where dsRNA or its degradation
products, including ssRNA fragments or a single strand of the
dsRNA [12], would be able to interact with TLR3, TLR7 or TLR9.
As a biological role for known dsRNA receptors, such as RIG-I,
PKR or TLR3, has not been demonstrated in human pDCs
[2,3,4,5,6], it is unlikely that these receptors are responsible for the
observed IFNa induction in this system, although RIG-I like
helicases have been recently implicated in the generation of a type I
IFN response in pDCs from IFN receptor knockout mice [14].
Signalingby a cytosolic receptor should be abrogated if inhibition of
endosomal acidification in turn prevented rotavirus entry into the
cytosol. However, the persistence and even increase of NSP2
expression following treatment with concanamycin A indicates that
pDC entry by rotavirus is conserved under conditions that alter
endosomal pH and decrease the pDC IFN response (Figure 8).
Figure 5. The effect of viral replication on IFNa induction and IRF7 phosphorylation. (A) Representative FACS plot of IFNa vs. NSP2
expression in pDCs stimulated with RRV 6hpi (moi 10). (B, C) pDCs from multiple donors were exposed to RRV and the percent of IFNa
+ (B) (n=26) or
IFNb
+ (C) (n=4) pDCs negative, dim or bright for NSP2 were determined. *:p=0.0286, ***: p#0.0006; Wilcoxon signed rank test. Donors with fewer
than 0.5% of pDCs staining positive for NSP2 were excluded from this analysis. (D) Representative histograms of IRF7 phosphorylation in NSP2
bright
(red), NSP2
dim (blue), and NSP2
- (green) pDCs 6 hours post RRV or mock (gray) stimulus. (E, F) Percent increase in pIRF7 (E) or total IRF7 (F) MFI by
indicated pDC populations relative to mock treated pDCs from multiple donors (n=6), 6 hours post RRV inoculation. *: p=0.0313; Wilcoxon signed
rank test.
doi:10.1371/journal.ppat.1000931.g005
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concanamycin A treatment supports the notion that an endosomal
receptor, such as TLR7 or TLR9, is involved in the initiation of the
pDC response to rotavirus. Hence we predict that dsRNA derived
from input virus is exposed following viral degradation, and not
replication, as inactivated RRV, but neither genome-free TLPs nor
VLPs, is sufficient for pDC activation/maturation and IFNa
production. While it is possible that recognition of some
combination of VP4, VP7 and dsRNA are required for IFNa
induction, we instead believe that viral entry—mediated by VP7
and/or VP4—and subsequent recognition of genomic dsRNA or its
degradation products are the critical components of this pathway.
The induction of both IFNa and TNFa by rotavirus may create
a synergistic effect in the suppression of viral replication, as has
been observed following RIG-I stimulus by myxoma virus [67].
Although the precise kinetics of induction are unclear, both TNFa
and IFNa are also observed in pDC supernatants following
influenza infection [24,68,69]. Interestingly, production of IFNa is
delayed until 14–20 h following infection with a laboratory strain
of H1N1 influenza, at which point ,4 ng/mL per million pDCs is
detectable; this production was dependent on viral replication
[69]. Conversely, we report that pDCs exposed to either live or
inactivated rotavirus secrete approximately 10 ng/mL of IFNa by
6hpi. In agreement with previous findings [14], the recognition of
secreted IFNa is an important component of the amplification of
the pDC IFNa response to both live and inactivated rotavirus. As
such, the recognition of input viral genome and subsequent
induction of an initial IFNa response prior to possible IRF7
inhibition allows for the establishment of an antiviral state by the
global pDC population. While inactivated herpes simplex virus
also induces IFNa, replication of vesicular stomatitis virus, Sendai
virus and human respiratory syncytial virus has been demonstrated
to be required for IFNa induction in pDCs [70,71]. Together, this
demonstration of rapid, potent, replication-independent induction
of cytokine by a dsRNA virus, largely dependent on endosomal
acidification, points to a novel mechanism leading to production of
IFNa by human pDCs.
Peripheral pDCs likely represent a significant source of the
systemic IFNa observed following in vivo rotavirus infection
[43,72,73,74]; the dispensability of proteolytic activation of VP4
Figure 6. The effect of trypsin activation of rotavirus on pDC infection and IFNa induction. (A, B) Representative FACS plots of IFNa and
NSP2 expression by pDCs exposed to equal quantities of non-trypsinized RRV (NT-RRV) with uncleaved (A, 3.77610
5 focus forming units/ml;
moi=0.079) or cleaved (B, 2.38610
7 focus forming units/ml; moi=5) VP4. (C, D) Summary of percent NSP2
+ and IFNa
+ pDCs from multiple donors
(n=3) following exposure to cleaved or uncleaved RRV. p$0.375; Wilcoxon signed rank test.
doi:10.1371/journal.ppat.1000931.g006
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mechanism for the establishment of the antiviral state extra-
intestinally by a small amount of virus. Increased levels of serum
IFNa have been reported in human pediatric patients infected
with rotavirus [43,44]; levels peaked within two days of symptom
onset and disease resolved more quickly in patients with the
highest levels of IFNa [43]. Likewise, type I IFN responses were
observed in newborn calves infected with bovine rotavirus: animals
receiving both high and low doses of viral inoculums generated
multiple waves of IFN production, with higher doses correlating
with both more rapid IFN responses and a lack of clinical signs
[74]. As the ability of type I IFN to activate multiple arms of the
innate and adaptive immune response is well documented
(reviewed in [75,76,77]), and recent data have shown that type I
IFN plays a critical role in restricting systemic rotavirus infection
[78], we predict that pDC-derived type I IFN plays a significant
role in confining rotavirus replication to the intestine while
initiating the systemic immune response in the periphery.
In summary, these studies show that primary human pDCs are
largely resistant to rotavirus replication, but that they remain
responsive and functional following viral exposure, as indicated by
cellular activation, maturation and production of multiple
cytokines, including TNFa and large amounts of IFNa. The
pDC response is demonstrated to require both the viral dsRNA
genome and acidification of the pDC endosome, implying the
likely initiation of the type I IFN response by TLR7 or TLR9. To
our knowledge, these data are the first to show that inactivated
rotavirus can efficiently induce a type I IFN response, which differs
from what has been seen in fibroblasts and epithelial cells exposed
to rotavirus [62]. The restricted ability of rotavirus to replicate in
pDCs, combined with the ability of the pDC to effect a type I IFN
response in the absence of viral replication, likely serves the
purposes of enabling the host to mount an innate antiviral
response despite the efficient degradation of the IRFs by rotavirus
NSP1 in many host cells. Combined with the novel dispensability
of trypsin cleavage of VP4 for the initiation of the pDC response,
this creates a mechanism for the establishment of an antiviral state
in the systemic extraintestinal environment and likely contributes
to the substantial restriction of systemic replication compared to
that observed in the intestine [38]. These experiments also provide
the first indication that rotavirus infection is capable of locally
suppressing IFNa production in primary human cells. Important-
ly, these findings demonstrate that rotavirus infection of primary
human pDCs provides a valuable experimental system for the
study of cellular processes, receptors and signaling pathways
underlying pDC-mediated antiviral immunity while revealing a
potentially novel dsRNA-mediated pathway of IFNa induction.
Materials and Methods
Virus preparation and inactivation
Simian (RRV and SA11) tissue-culture adapted rotaviruses were
grown in fetal monkey kidney (MA104) cells in the presence of
trypsin, except where noted, as previously described [79,80].
Where indicated, RRV empty and genome-containing TLPs were
purified from MA104 cell lysates by cesium chloride density
gradient centrifugation following genetron extraction and pelleting
through a sucrose cushion, as previously described [81,82]. DLPs
were created by treating TLPs with 20 nM EDTA, thus removing
the outer viral proteins VP4 and VP7, as previously described
[32]. Purified viral preparations were dialyzed to remove residual
cesium chloride prior to pDC stimulus. A portion of the RRV
lysate preparation was inactivated by treatment with 40 mg/ml
psoralen, followed by exposure to ultraviolet light for 40 minutes,
as described [83]. The inactivation of infectivity and transcrip-
tional activity of the RRV in the psoralen preparations was
Figure 7. Viral determinants of IFNa induction. Representative FACS plots of IFNa production by pDCs at 12 hours post exposure to rotavirus-
derived stimuli. RRV: live virus; iRRV: inactivated virus; TLP: purified triple-layered (2/4/6/7) genome-containing virus particles; DLP: purified double-
layered (2/6) genome-containing virus particles; SA11: live virus strain from which VLPs are derived; 2/4/6/7 VLPs: recombinant genome-free virus-like
particles; empty particles: purified genome-free TLPs.
doi:10.1371/journal.ppat.1000931.g007
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RNA polymerase activity by in vitro assay. Except where noted,
viral preparations were trypsin activated (5 mg/ml) at 37uC for 20–
30 minutes prior to pDC infection. Preparations were endotoxin-
free, as determined by Limulus amebocyte lysate test (Charles
River, Wilmington, MA).
Virus-like particles
Rotavirus-like particles (VLPs) expressing VP2 and VP6 (2/6
VLPs), or VP2, VP6 and VP7 (2/6/7 VLPs), were generated by
coinfecting Spodoptera frugiperda 9 cells with two or three
recombinant baculoviruses, respectively, at a moi $5 plaque
forming units per cell, as previously described [84]. Briefly, the
baculoviruses expressed RF (bovine rotavirus) VP6, RRV VP7, or
a fusion protein consisting of GFP fused to the N terminus of RF
VP2 deleted in the first 92 amino acids. Infected cultures were
collected 5–7 days post infection and purified by cesium chloride
density gradient centrifugation. VLPs composed of RF VP2, SA11
Cl3 VP6, SA11 Cl3 VP7 and SA11 4F VP4 (2/4/6/7 VLPs) were
similarly prepared, as previously described [85,86,87]. The protein
concentration of the purified VLP preparations was estimated by
the Bradford method.
Virus and VLP quantification
All viral preparations were titrated by plaque assay on MA104
cells and expressed as plaque forming units per ml, as described
[80]. Hemagglutination assays were performed to determine VP4
content of purified genome-containing and empty TLPs, unpur-
ified RRV and 2/4/6/7 VLPs, as described [88], and used to
ensure that equal quantities of TLPs were added to pDC
preparations. Additionally, DLPs were prepared by treating
purified genome-containing TLPs with 20 nM of EDTA, thus
removing the outer capsid from the virion and resulting in equal
particle counts between the two preparations.
Isolation of primary human pDCs
PBMCs were isolated from leukoreduction chambers obtained
from the Stanford Blood Center (Palo Alto, CA) by centrifugation
over ficoll-hypaque (GE Healthcare, Uppsala, Sweden). Plasma-
cytoid DCs were negatively selected using the pDC Isolation Kit
(Miltenyi Biotec, Auburn, CA), according to manufacturer’s
instructions. To increase the purity of the pDC preparations,
consecutive purifications were performed using an AutoMACS
(Miltenyi Biotec, Auburn, CA). An average of 2 million pDCs,





isolated per donor; preparations were routinely .85% pure.
pDC culture, infection, stimulation and blocking studies
Approximately 2610
5 pDCs were exposed to rotavirus particles
or 4 mg/mL CpG ODN 2395 (Coley Pharmaceuticals, Ottawa,
Canada), as indicated, for 1 hour in serum-free RPMI-1640
(CellGro, Manassas, VA) supplemented with penicillin/strepto-
mycin and L-glutamine (Gibco, Carlsbad CA). pDCs were washed
and suspended at a concentration of 1 million pDCs/mL in
Figure 8. The effects of concanamycin A on IFNa induction and NSP2 expression. Intracellular IFNa was assessed in untreated or
concanamycin A-treated pDCs following exposure to RRV (A) or iRRV (B). (C) Relative frequency of IFNa
+ pDCs in untreated or concanamycin A-
treated pDCs from multiple donors (n=6) following exposure to live or inactivated rotavirus. **: p=0.0097; Mann-Whitney. (D) Fold increase in NSP2
expression by pDCs from multiple donors (n=6) treated with concanamycin A prior to infection, compared to expression by untreated pDCs.
*: p=0.0313; Wilcoxon signed rank test. (E) Representative FACS plots depicting NSP2 staining in untreated and concanamycin A-treated pDCs
following RRV exposure.
doi:10.1371/journal.ppat.1000931.g008
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(Hyclone, Logan, UT), penicillin/streptomycin, L-glutamine and
10 ng/mL IL3 (Peprotech, Rocky Hill, NJ) until harvest. Where
indicated, rotavirus infection was blocked using neutralizing
monoclonal antibodies to VP5 (mAb 2G4) or VP7 (mAb 159),
or as a non-neutralizing control, a VP6 monoclonal antibody
(mAb 1E11). In studies determining whether pDC infection was
productive, highly-purified pDCs (mean purity: 91.51%) were
exposed to RRV at an moi of 10 for one hour; neutralizing mAb
159 was then added for 30 minutes. pDCs were washed 3 times,
and were frozen immediately or after overnight culture. The
resulting pDC pellets and supernatants were freeze/thawed three
times, and virus titer determined by FFU assay, as previously
described [89].
Inhibition of endosomal acidification
Purified pDCs were incubated with 20 nM concanamycin A
(Sigma-Aldrich, St Louis, MO) at 37 degrees for one hour prior to
infection with live or inactivated RRV (moi 10).
Flow cytometry (FACS)
Supernatants were harvested by centrifugation of cultured
pDCs, which were then washed once with PBS (CellGro,
Manassas, VA). The LIVE/DEAD Aqua Dead Cell Stain Kit
(Invitrogen, Carlsbad, CA) was utilized to assess cellular viability
via amine exclusion. Surface staining was performed using
antibodies against human CD3, CD14, CD16, HLA-DR, CD83,
CD86, CD123 (BD Biosciences, San Jose, CA), CD11c, CD19,
CD20 (eBioscience, San Diego, CA), and BDCA2 (Miltenyi





+. Cellular fixation and permeabilization were
performed using Cytofix/Cytoperm (BD Biosciences, San Jose,
CA), per the manufacturer’s instructions. Following blocking of Fc
receptors (Miltenyi Biotec, Auburn, CA), intracellular staining was
performed with antibodies to IFNa, total IRF7, phosphorylated
IRF7 (pS477/pS479) (BD Biosciences, San Jose, CA), IFNb
(Antigenix America, Huntington Station, NY) or NSP2 (mAb 191).
The presence of NSP2 staining of exposed pDCs was considered to
be indicative of rotaviral replication in those cells. Direct
conjugation of mAb 191 to APC was performed by Chromaprobe
Inc (Maryland Heights, MO). Data were acquired using a LSRII
and DIVA software (BD Biosciences, San Jose, CA); analysis was
performed using FlowJo (Treestar Inc, Ashland, OR).
Detection of secreted cytokines and chemokines
Supernatants of cultures .85% (mean 6 SEM:
90.84%60.7499) pure for pDCs were analyzed by Luminex using
MILLIPLEX MAP (Millipore, Billerica, MA) per the manufac-
turer’s instructions for the presence of IFNa, IFNc, TNFa, TNFb,
IL1b, IL1RA, IL2, IL4, IL6, IL8, IL10, IL12p40, IL12p70,
CXCL10 (IP10), CCL3 (MIP1a), CCL4 (MIP1b), CCL5
(RANTES) and sCD40L. Secreted IFNb was detected by ELISA,
per the manufacturer’s instructions (PBL Interferon Source,
Piscataway, NJ).
Statistical analysis
Mann-Whitney and Wilcoxon signed rank tests were performed
using GraphPad Prism (GraphPad Software Inc, La Jolla, CA). A
p-value of #0.05 was considered significant.
Supporting Information
Figure S1 pDC gating strategy. (A-D) pDCs were defined in






cells. (E) Representative FACS plot demonstrating BDCA2 vs.
NSP2 staining of pDCs (red) vs. contaminating HLA-DR- (blue)
cells exposed to RRV (n=12).
Found at: doi:10.1371/journal.ppat.1000931.s001 (0.39 MB TIF)
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